Literature DB >> 20716962

The MUC1-C oncoprotein as a target in hematologic malignancies.

Jeffrey Schlom1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20716962      PMCID： PMC3230282          DOI： 10.4161/cbt.10.5.13150

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  12 in total

1.  Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.

Authors:  Deepak Raina; Rehan Ahmad; Maya Datt Joshi; Li Yin; Zekui Wu; Takeshi Kawano; Baldev Vasir; David Avigan; Surender Kharbanda; Donald Kufe
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

2.  Terminal differentiation of chronic myelogenous leukemia cells is induced by targeting of the MUC1-C oncoprotein.

Authors:  Li Yin; Rehan Ahmad; Michio Kosugi; Takeshi Kawano; David Avigan; Richard Stone; Surender Kharbanda; Donald Kufe
Journal:  Cancer Biol Ther       Date:  2010-09-04       Impact factor: 4.742

3.  MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin.

Authors:  Lei Huang; Dongshu Chen; Derek Liu; Li Yin; Surender Kharbanda; Donald Kufe
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

4.  Segregation of receptor and ligand regulates activation of epithelial growth factor receptor.

Authors:  Paola D Vermeer; Lisa A Einwalter; Thomas O Moninger; Tatiana Rokhlina; Jeffrey A Kern; Joseph Zabner; Michael J Welsh
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

Review 5.  Mucins in cancer: function, prognosis and therapy.

Authors:  Donald W Kufe
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

6.  Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors.

Authors:  D Kufe; G Inghirami; M Abe; D Hayes; H Justi-Wheeler; J Schlom
Journal:  Hybridoma       Date:  1984

Review 7.  Translation of the Philadelphia chromosome into therapy for CML.

Authors:  Brian J Druker
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

8.  Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62.

Authors:  Yumei Leng; Cheng Cao; Jian Ren; Lei Huang; Dongshu Chen; Masaki Ito; Donald Kufe
Journal:  J Biol Chem       Date:  2007-05-11       Impact factor: 5.157

9.  MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells.

Authors:  Takeshi Kawano; Masaki Ito; Deepak Raina; Zekui Wu; Jacalyn Rosenblatt; David Avigan; Richard Stone; Donald Kufe
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

Review 10.  Functional targeting of the MUC1 oncogene in human cancers.

Authors:  Donald W Kufe
Journal:  Cancer Biol Ther       Date:  2009-07-27       Impact factor: 4.742
View more
  1 in total

Review 1.  MUC1 in hematological malignancies.

Authors:  Dina Stroopinsky; Donald Kufe; David Avigan
Journal:  Leuk Lymphoma       Date:  2016-06-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.